Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by CD Poole
PWE-153 Cost Effectiveness of Rifaximin-A in the Reduction of Recurrence of Overt Hepatic Encephalopathy
Gut
Gastroenterology
Related publications
Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Economic Impact of the Use of Rifaximin 550 Mg Twice Daily for the Treatment of Overt Hepatic Encephalopathy in Italy
Hepatic Medicine: Evidence and Research
Hepatology
Prevention of Hepatic Encephalopathy Recurrence
Clinical Liver Disease
Hepatology
Safety, Efficacy, and Patient Acceptability of Rifaximin for Hepatic Encephalopathy
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
L-Ornithine L-Aspartate in Bouts of Overt Hepatic Encephalopathy
Hepatology
Medicine
Hepatology
Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction
ASN Neuro
Neuroscience
Neurology
Grading the Range of Hepatic Encephalopathy From Overt to Covert: Animals to the Rescue!
Hepatology
Medicine
Hepatology
Rifaximin for the Prevention and Treatment of Hepatic Encephalopathy: A Systematic Review With Meta-Analyses of Randomised Controlled Trials
Journal of Clinical and Experimental Hepatology
Hepatology
Terminating an Episode of Overt Hepatic Encephalopathy- Lornithine L-Aspartate May Have Some Role
Hepatology
Medicine
Hepatology